Public Announcement

Buyback Premium Above 10pctCorporate Actions View source PDF

ZYDUSLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-0.2%1-day move

₹1040.30

prior close

₹1034.40

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.3+0.4+0.3+0.2-0.2+3.0+3.5+4.5+4.0+3.8+6.0+4.4+10.2—

Up moveDown movePending

AI summary

Zydus Lifesciences Limited has announced a buyback of up to 95,65,217 equity shares (0.95% of paid-up capital) at INR 1,150 per share for a total amount not exceeding INR 1,100 crore. The buyback price represents a 23.88% premium over the volume weighted average price on NSE and a 26.14% premium over the 3-month average price. The tender offer will open from June 4, 2026 to June 10, 2026, with May 29, 2026 as the record date. The company states this is to distribute surplus cash to shareholders, optimize returns, and enhance shareholder value. The promoter group holds approximately 75.46% stake and may participate in the buyback.

Likely market impact

The significant premium (23-26%) offered signals management confidence in the company's intrinsic value. Shareholders who tender will receive a 23-26% premium over recent market prices, which could provide near-term support to the stock price.